CALR and anemia: Notably, the cumulative incidence of anemia was lower in PMF patients harboring the driver CALR mutation versus JAK2- and MPL- mutants; conversely, “triple negative” patients for the three driver mutations manifested the highest cumulative incidence of anemia [27].